thiazolidines has been researched along with Carcinoma, Lewis Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, J; Gao, J; Guo, W; Li, A; Wu, T; Zhou, H | 1 |
| Ji, H; Lai, Y; Li, Y; Sun, Y; Ye, X; Zhang, Y; Zhou, W | 1 |
2 other study(ies) available for thiazolidines and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Pidotimod enhanced the anti-growth effect of cisplatin on lung cancer in mice via promoting anti-tumor immune response.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Proliferation; Cisplatin; Dendritic Cells; Drug Synergism; Immunity; Mice; Pyrrolidonecarboxylic Acid; Thiazolidines | 2020 |
Darbufelone, a novel anti-inflammatory drug, induces growth inhibition of lung cancer cells both in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspase 8; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Enzyme Activation; Flow Cytometry; Humans; Immunohistochemistry; Lung Neoplasms; Mice; Reverse Transcriptase Polymerase Chain Reaction; Thiazolidines | 2010 |